Masahiro Goto Selected Research

Masahiro Goto Research Topics

Disease

42	Neoplasms (Cancer) 11/2023 - 04/2002
34	Stomach Neoplasms (Stomach Cancer) 04/2024 - 01/2005
19	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 01/2013
10	Neoplasm Metastasis (Metastasis) 11/2023 - 04/2006
6	Disease Progression 10/2021 - 01/2009
5	Adenocarcinoma 03/2023 - 02/2014
5	Hypersensitivity (Allergy) 08/2020 - 01/2018
5	Seasonal Allergic Rhinitis (Hay Fever) 03/2020 - 12/2015
4	Neutropenia 09/2023 - 10/2013
4	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2023 - 10/2011
4	Hepatocellular Carcinoma (Hepatoma) 06/2022 - 11/2016
4	Nausea 03/2021 - 01/2006
3	Esophageal Neoplasms (Esophageal Cancer) 04/2024 - 06/2003
3	Infections 03/2024 - 11/2004
3	Mycoses (Diseases, Fungus) 03/2024 - 01/2022
3	Febrile Neutropenia 09/2023 - 01/2015
3	Diarrhea 01/2023 - 02/2018
3	Ascites 01/2022 - 09/2012
3	Pancreatic Neoplasms (Pancreatic Cancer) 11/2021 - 01/2015
3	Vomiting 03/2021 - 01/2006
3	Dehydration (Water Stress) 08/2020 - 01/2009
2	Out-of-Hospital Cardiac Arrest 01/2024 - 01/2023
2	Hemorrhage 01/2024 - 02/2021
2	COVID-19 11/2022 - 01/2021
2	Squamous Cell Carcinoma of Head and Neck 10/2020 - 10/2017
2	Carcinoma (Carcinomatosis) 01/2020 - 04/2002
2	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 07/2015 - 01/2015
2	Anorexia 10/2013 - 08/2002
2	Hypertension (High Blood Pressure) 09/2013 - 10/2011
1	Lymphatic Metastasis 01/2024
1	Brain Neoplasms (Brain Tumor) 11/2023
1	Brain Stem Infarctions (Weber Syndrome) 06/2023

Drug/Important Bio-Agent (IBA)

15	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2024 - 01/2013
12	Irinotecan (Camptosar)FDA LinkGeneric 09/2023 - 01/2007
9	Cisplatin (Platino)FDA LinkGeneric 09/2023 - 09/2012
9	AntigensIBA 03/2023 - 12/2015
8	Fluorouracil (Carac)FDA LinkGeneric 05/2022 - 09/2012
8	Paclitaxel (Taxol)FDA LinkGeneric 10/2021 - 04/2006
7	Proteins (Proteins, Gene)FDA Link 11/2022 - 01/2018
6	Capecitabine (Xeloda)FDA Link 11/2023 - 01/2020
6	Panitumumab (Vectibix)FDA Link 01/2023 - 06/2019
6	Bevacizumab (Avastin)FDA Link 09/2022 - 01/2013
6	Peptides (Polypeptides)IBA 01/2019 - 01/2015
5	pembrolizumabIBA 04/2024 - 01/2022
5	VaccinesIBA 01/2023 - 05/2019
5	Leucovorin (Folinic Acid)FDA Link 03/2021 - 09/2012
4	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2020
4	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023 - 01/2006
4	Ionic LiquidsIBA 01/2022 - 01/2018
4	NivolumabIBA 01/2022 - 10/2017
3	Trastuzumab (Herceptin)FDA Link 04/2024 - 11/2019
3	Docetaxel (Taxotere)FDA Link 01/2024 - 07/2022
3	B7-H1 AntigenIBA 09/2023 - 10/2022
3	Circulating Tumor DNAIBA 01/2023 - 12/2020
3	LipidsIBA 09/2022 - 01/2015
3	S-1 plus cisplatinIBA 10/2021 - 04/2014
3	Cancer VaccinesIBA 01/2020 - 01/2018
3	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 08/2017 - 12/2015
3	Immunoglobulin E (IgE)IBA 08/2017 - 12/2015
3	Adrenocorticotropic Hormone (ACTH)FDA Link 07/2016 - 01/2007
3	Prednisolone (Predate)FDA LinkGeneric 01/2016 - 01/2015
3	EnzymesIBA 12/2015 - 01/2007
2	Amphotericin B (Amphotericin)FDA LinkGeneric 03/2024 - 01/2022
2	AcidsIBA 01/2023 - 09/2012
2	Cetuximab (Erbitux)FDA Link 09/2022 - 01/2020
2	RamucirumabIBA 07/2022 - 11/2020
2	PlatinumIBA 05/2022 - 10/2017
2	Cytotoxins (Cytolysins)IBA 03/2022 - 05/2021
2	regorafenibIBA 01/2022 - 10/2021
2	AntibodiesIBA 01/2022 - 01/2022
2	folfirinoxIBA 11/2021 - 01/2015
2	CytokinesIBA 08/2021 - 08/2017
2	trifluridine tipiracil drug combinationIBA 07/2021 - 12/2018
2	AntiemeticsIBA 03/2021 - 01/2006
2	resiquimodIBA 05/2019 - 01/2018
2	Capsules (Microcapsules)IBA 02/2019 - 02/2018
2	130-nm albumin-bound paclitaxelIBA 01/2019 - 07/2014
2	HydrogelsIBA 01/2019 - 11/2016
2	GlucocorticoidsIBA 07/2016 - 01/2009
2	Hydrocortisone (Cortisol)FDA LinkGeneric 07/2016 - 07/2015
2	Intravenous Immunoglobulins (IVIG)FDA Link 07/2015 - 01/2015
2	doxifluridineIBA 03/2008 - 04/2006
1	liposomal amphotericin B FDA Link 03/2024
1	Carcinoembryonic AntigenIBA 01/2024
1	Angiogenesis InhibitorsIBA 01/2024
1	S 1 (combination)IBA 09/2023
1	NanovaccinesIBA 03/2023

Therapy/Procedure

37	Drug Therapy (Chemotherapy) 04/2024 - 01/2005
31	Therapeutics 11/2023 - 01/2006
11	Immunotherapy 01/2022 - 12/2015
7	Gastrectomy 01/2024 - 04/2014
7	Combination Drug Therapy (Combination Chemotherapy) 05/2022 - 04/2006
5	Adjuvant Chemotherapy 01/2024 - 04/2014
5	Hepatectomy 06/2022 - 10/2019
3	Cardiopulmonary Resuscitation (CPR) 01/2024 - 01/2023
3	Premedication 01/2023 - 07/2014
2	Blood Transfusion (Blood Transfusions) 01/2024 - 02/2021
2	Neoadjuvant Therapy 03/2021 - 01/2020
2	Chemoradiotherapy 06/2020 - 06/2003
1	Length of Stay 01/2024